147 related articles for article (PubMed ID: 2821552)
1. Different genes specify hyporesponsiveness to seizures induced by caffeine and the benzodiazepine inverse agonist, DMCM.
Seale TW; Abla KA; Roderick TH; Rennert OM; Carney JM
Pharmacol Biochem Behav; 1987 Jul; 27(3):451-6. PubMed ID: 2821552
[TBL] [Abstract][Full Text] [Related]
2. Coincidence of seizure susceptibility to caffeine and to the benzodiazepine inverse agonist, DMCM, in SWR and CBA inbred mice.
Seale TW; Carney JM; Rennert OM; Flux M; Skolnick P
Pharmacol Biochem Behav; 1987 Feb; 26(2):381-7. PubMed ID: 3575358
[TBL] [Abstract][Full Text] [Related]
3. DMCM: a potent convulsive benzodiazepine receptor ligand.
Petersen EN
Eur J Pharmacol; 1983 Oct; 94(1-2):117-24. PubMed ID: 6317396
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
[TBL] [Abstract][Full Text] [Related]
5. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
6. Protection against the lethal effects of pentobarbital in mice by a benzodiazepine receptor inverse agonist, 6,7-dimethoxy-4-ethyl-3-carbomethoxy-beta-carboline.
Havoundjian H; Reed GF; Paul SM; Skolnick P
J Clin Invest; 1987 Feb; 79(2):473-7. PubMed ID: 3027125
[TBL] [Abstract][Full Text] [Related]
7. A single gene difference determines relative susceptibility to caffeine-induced lethality in SWR and CBA inbred mice.
Seale TW; Johnson P; Roderick TH; Carney JM; Rennert OM
Pharmacol Biochem Behav; 1985 Aug; 23(2):275-8. PubMed ID: 4059313
[TBL] [Abstract][Full Text] [Related]
8. Complex genetic determinants of susceptibility to methylxanthine-induced locomotor activity changes.
Seale TW; Roderick TH; Johnson P; Logan L; Rennert OM; Carney JM
Pharmacol Biochem Behav; 1986 May; 24(5):1333-41. PubMed ID: 3725837
[TBL] [Abstract][Full Text] [Related]
9. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
Im HK; Im WB; Carter DB; McKinley DD
Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine receptors studied in living primates by positron emission tomography: inverse agonist interactions.
Hantraye P; Chavoix C; Guibert B; Fukuda H; Brouillet E; Dodd RH; Prenant C; Crouzel M; Naquet R; Mazière M
Eur J Pharmacol; 1987 Jun; 138(2):239-47. PubMed ID: 3040433
[TBL] [Abstract][Full Text] [Related]
11. Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM.
Nutt DJ; Little HJ; Taylor SC; Minchin MC
Eur J Pharmacol; 1984 Aug; 103(3-4):359-62. PubMed ID: 6092108
[TBL] [Abstract][Full Text] [Related]
12. beta-Carboline-induced seizures in mice: genetic analysis.
Desforges C; Venault P; Dodd RH; Chapouthier G; Roubertoux PL
Pharmacol Biochem Behav; 1989 Dec; 34(4):733-7. PubMed ID: 2560211
[TBL] [Abstract][Full Text] [Related]
13. Modulation of gamma-aminobutyric acidA receptor-operated chloride channels by benzodiazepine inverse agonists is related to genetic differences in ethanol withdrawal seizure severity.
Buck KJ; McQuilkin SJ; Harris RA
J Neurochem; 1991 Dec; 57(6):2100-5. PubMed ID: 1658234
[TBL] [Abstract][Full Text] [Related]
14. Behavioral differences between subgroups of rats with high and low threshold to clonic convulsions induced by DMCM, a benzodiazepine inverse agonist.
Contó MB; de Carvalho JG; Benedito MA
Pharmacol Biochem Behav; 2005 Nov; 82(3):417-26. PubMed ID: 16297441
[TBL] [Abstract][Full Text] [Related]
15. Agonistic effects of the beta-carboline DMCM revealed in GABA(A) receptor gamma 2 subunit F77I point-mutated mice.
Leppä E; Vekovischeva OY; Lindén AM; Wulff P; Oberto A; Wisden W; Korpi ER
Neuropharmacology; 2005 Mar; 48(4):469-78. PubMed ID: 15755475
[TBL] [Abstract][Full Text] [Related]
16. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
17. Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.
Kulick C; Gutherz S; Kondratyev A; Forcelli PA
Eur J Pharmacol; 2014 Oct; 740():662-8. PubMed ID: 24967532
[TBL] [Abstract][Full Text] [Related]
18. Gestational exposure to diazepam increases sensitivity to convulsants that act at the GABA/benzodiazepine receptor complex.
Bitran D; Primus RJ; Kellogg CK
Eur J Pharmacol; 1991 Apr; 196(3):223-31. PubMed ID: 1654253
[TBL] [Abstract][Full Text] [Related]
19. Strain differences in sensitivity to the hypothermic effects of benzodiazepine receptor ligands in mice.
Jackson HC; Nutt DJ
Psychopharmacology (Berl); 1992; 109(3):365-8. PubMed ID: 1365636
[TBL] [Abstract][Full Text] [Related]
20. Effects of the benzodiazepine receptor inverse agonist, DMCM, on the behaviour of mice: an ethopharmacological study.
Cutler MG; Aitken CC
Neuropharmacology; 1991 Dec; 30(12A):1255-61. PubMed ID: 1664917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
